// App-Quantinova.ai

P5-08-45 : The predictive potential of metastatic serum markers and circulating tumor cells in advanced HER2-positive breast cancer patients - Focused on CNS metastases

Researchers

Presenter

  • Mikulova V

Principal Investigators

  • Jancikova M

  • Tesarova P

  • Zima T

Medical Centers

  • General University Hospital in Prague and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

  • Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

  • Matrix metallopeptidase 9

  • Matrix metalloproteinase 2

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved